{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:31Z","timestamp":1789778971379,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000895","name":"St. Jude Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD065987"],"award-info":[{"award-number":["K12HD065987"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mayocp.2019.06.015","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T18:07:58Z","timestamp":1575310078000},"page":"2455-2466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary\u00a0Syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Behnam","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-5313","authenticated-orcid":false,"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni Z.","family":"Lalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7108-0499","authenticated-orcid":false,"given":"Alice Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.015_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000455233","article-title":"Cardiometabolic risks in polycystic ovary syndrome: non-traditional risk factors and the impact of obesity","volume":"104","author":"Chiu","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.mayocp.2019.06.015_bib3","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.015_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.mayocp.2019.06.015_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.015_bib6","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-16-1063","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.015_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejogrb.2007.02.011","article-title":"Evaluation of endothelial function in women with polycystic ovary syndrome","volume":"134","author":"Lowenstein","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.015_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12803","article-title":"Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance","volume":"83","author":"Lambert","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.06.015_bib10","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.015_bib11","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.015_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","article-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","volume":"93","author":"Teede","year":"2010","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.015_bib14","article-title":"Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis","volume":"4","author":"Matsuzawa","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.mayocp.2019.06.015_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.015_bib17","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","article-title":"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia","volume":"44","author":"Bonetti","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2019.06.015_bib18","first-page":"1961","article-title":"Impaired glucose tolerance and\u00a0impaired fasting glucose","volume":"69","author":"Rao","year":"2004","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.mayocp.2019.06.015_bib19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/HJH.0b013e328362d913","article-title":"Reproducibility of peripheral arterial tonometry for the assessment of endothelial function in adults","volume":"31","author":"Brant","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"41","key":"10.1016\/j.mayocp.2019.06.015_bib20","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/eht351","article-title":"Endothelial dysfunction over the course\u00a0of coronary artery disease","volume":"34","author":"Guti\u00e9rrez","year":"2013","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.mayocp.2019.06.015_bib21","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2009.10.073","article-title":"Digital assessment of endothelial function and ischemic heart disease in women","volume":"55","author":"Matsuzawa","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1358863X11433188","article-title":"Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design","volume":"17","author":"McCrea","year":"2012","journal-title":"Vasc Med"},{"issue":"10","key":"10.1016\/j.mayocp.2019.06.015_bib23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","article-title":"Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease","volume":"41","author":"Bonetti","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2019.06.015_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12933-016-0353-1","article-title":"Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects","volume":"15","author":"Westergren","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.015_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","article-title":"Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial","volume":"95","author":"Agarwal","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.015_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.015_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12723","article-title":"Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults","volume":"17","author":"Kulkarni","year":"2018","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.mayocp.2019.06.015_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.numecd.2017.04.009","article-title":"Metformin effects on the heart and the cardiovascular system: a review of experimental and clinical data","volume":"27","author":"Nesti","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.015_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/apha.12644","article-title":"Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium","volume":"219","author":"Triggle","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"issue":"9","key":"10.1016\/j.mayocp.2019.06.015_bib30","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","article-title":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome","volume":"60","author":"Sam","year":"2017","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.mayocp.2019.06.015_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MCA.0000000000000178","article-title":"Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment","volume":"25","author":"Matsuzawa","year":"2014","journal-title":"Coron Artery Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.015_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.015_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2008.08.074","article-title":"Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease","volume":"53","author":"Kitta","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.015_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0735-1097(02)01976-9","article-title":"Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women","volume":"40","author":"Modena","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.015_bib35","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.015_bib36","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mayocp.2019.06.015_bib37","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"Hum Reprod"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619306317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619306317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:27:23Z","timestamp":1577813243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619306317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0025619619306317"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.015","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary\u00a0Syndrome","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}